Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Finch

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Experimental Cell Research|July 17, 1998
Identification of a repressor of the differentiation of WEHI-3B D- leukemia cellsJ Li, R A Finch, W Xiao, et al.
Southern Medical Journal|October 1, 1979
Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresisR A Finch, E A Rutsky, E McGowan, et al.
Blood|September 9, 2000
Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid-treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiationR A Finch, J Li, T C Chou, et al.
Cancer Research|April 18, 2001
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activityR A Finch, K Shyam, P G Penketh, et al.
Drug and Chemical Toxicology|May 22, 2001
Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixturesD J Fort, R L Rogers, E L Stover, et al.
Journal of Applied Toxicology : JAT|February 1, 1992
Teratogenic assessment of four solvents using the Frog Embryo Teratogenesis Assay--Xenopus (FETAX)T H Dresser, E R Rivera, F J Hoffmann, et al.
Teratogenesis, Carcinogenesis, and Mutagenesis|December 22, 1999
Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxificationD J Fort, E L Stover, J A Bantle, et al.
Cancer Letters|March 1, 1990
Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMPZ Parandoosh, B Rubalcava, R A Finch, et al.
Cancer Research|December 11, 1997
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathioneA Lorico, G Rappa, R A Finch, et al.
Journal of Medicinal Chemistry|February 1, 1990
1,2,4-Diazaphosphole nucleosides. Synthesis, structure, and antitumor activity of nucleosides with a lambda 3 phosphorus atomT A Riley, S B Larson, T L Avery, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Experimental Cell Research|July 17, 1998
Identification of a repressor of the differentiation of WEHI-3B D- leukemia cellsJ Li, R A Finch, W Xiao, et al.
Southern Medical Journal|October 1, 1979
Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresisR A Finch, E A Rutsky, E McGowan, et al.
Blood|September 9, 2000
Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid-treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiationR A Finch, J Li, T C Chou, et al.
Cancer Research|April 18, 2001
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activityR A Finch, K Shyam, P G Penketh, et al.
Drug and Chemical Toxicology|May 22, 2001
Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixturesD J Fort, R L Rogers, E L Stover, et al.
Journal of Applied Toxicology : JAT|February 1, 1992
Teratogenic assessment of four solvents using the Frog Embryo Teratogenesis Assay--Xenopus (FETAX)T H Dresser, E R Rivera, F J Hoffmann, et al.
Teratogenesis, Carcinogenesis, and Mutagenesis|December 22, 1999
Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxificationD J Fort, E L Stover, J A Bantle, et al.
Cancer Letters|March 1, 1990
Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMPZ Parandoosh, B Rubalcava, R A Finch, et al.
Cancer Research|December 11, 1997
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathioneA Lorico, G Rappa, R A Finch, et al.
Journal of Medicinal Chemistry|February 1, 1990
1,2,4-Diazaphosphole nucleosides. Synthesis, structure, and antitumor activity of nucleosides with a lambda 3 phosphorus atomT A Riley, S B Larson, T L Avery, et al.
Pageof 5